GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » Intermolecular Inc (NAS:IMI) » Definitions » Financial Strength

Intermolecular (Intermolecular) Financial Strength : 0 (As of Jun. 2019)


View and export this data going back to 2011. Start your Free Trial

What is Intermolecular Financial Strength?

Intermolecular has the Financial Strength Rank of 0.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

GuruFocus does not calculate Intermolecular's interest coverage with the available data. Intermolecular's debt to revenue ratio for the quarter that ended in Jun. 2019 was 0.74. As of today, Intermolecular's Altman Z-Score is 0.00.


Competitive Comparison of Intermolecular's Financial Strength

For the Semiconductor Equipment & Materials subindustry, Intermolecular's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intermolecular's Financial Strength Distribution in the Semiconductors Industry

For the Semiconductors industry and Technology sector, Intermolecular's Financial Strength distribution charts can be found below:

* The bar in red indicates where Intermolecular's Financial Strength falls into.



Intermolecular Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Intermolecular's Interest Expense for the months ended in Jun. 2019 was $0.00 Mil. Its Operating Income for the months ended in Jun. 2019 was $-5.50 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2019 was $11.83 Mil.

Intermolecular's Interest Coverage for the quarter that ended in Jun. 2019 is

GuruFocus does not calculate Intermolecular's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Intermolecular's Debt to Revenue Ratio for the quarter that ended in Jun. 2019 is

Debt to Revenue Ratio=Total Debt (Q: Jun. 2019 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.816 + 11.832) / 18.472
=0.74

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Intermolecular has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intermolecular  (NAS:IMI) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Intermolecular has the Financial Strength Rank of 0.


Intermolecular Financial Strength Related Terms

Thank you for viewing the detailed overview of Intermolecular's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Intermolecular (Intermolecular) Business Description

Traded in Other Exchanges
N/A
Address
3011 North First Street, San Jose, CA, USA, 95134
Intermolecular Inc operates in the technology sector based in the United States. It manufactures and sells support materials for the semiconductor industry. Its HPC platform, which consists of the Tempus processing tools, automated characterization methods and Informatics analysis software, is purpose-built for research and development ("R&D") using combinatorial process systems in concert with established CVD, physical vapor deposition ("PVD") and atomic layer deposition ("ALD") deposition methods. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies primarily in the Asia-Pacific region.
Executives
Raging Capital Management, Llc 10 percent owner TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553-0228
Christian Kramer director, officer: President and CEO 6 DAVIS AVE APT B22, RYE NY 10580
Irwin Federman 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
Kenneth H Traub director
William C Martin 10 percent owner C/O RAGING CAPITAL MANAGEMENT, LLC, TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553
Bill Roeschlein officer: Chief Financial Officer C/O SELECTICA, INC., 3 WEST PLUMERIA, SAN JOSE CA 95134
George Scalise director
Marvin D Burkett director C/O ENTEGRIS, INC., 129 CONCORD ROAD, BILLERICA MA 01821
Redpoint Ventures Ii, L.p. 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Redpoint Associates Ii, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Redpoint Ventures Ii, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Neil S Subin other: Former 10% Owner 2336 S.E. OCEAN BOULEVARD, #400, STUART FL 34996
Presidio Management Group Ix, L.l.c. 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
Steven M Krausz 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
U S Venture Partners Ix L P 10 percent owner 2735 SAND HILL RD, MENLO PARK CA 94025

Intermolecular (Intermolecular) Headlines

From GuruFocus

Intermolecular Sets December 2018 Financial Conference Schedule

By PRNewswire PRNewswire 11-27-2018

WeissLaw LLP Investigates Intermolecular, Inc. Acquisition

By PRNewswire PRNewswire 05-16-2019